Aug 5 (Reuters) – Mironid: * MIRONID RAISES $46 MILLION IN SERIES B FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF ITS TREATMENT FOR RARE KIDNEY DISEASE Source text: Further company coverage: [ ]
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Analysis-Nudge from Bessent firms case for BOJ rate hike in September
By Leika Kihara TOKYO, Aug 5 (Reuters) - U.S. Treasury Secretary Scott Bessent's public views…
Jamie Foxx headline hostage action thriller 'Deadlocked' for Amazon MGM Studios
Los Angeles [US], August 5 (ANI): Academy Award-winning actor Jamie Foxx has found his next…
TIMELINE: FIFA scraps World Cup stake plan, reactions to the proposal across world soccer
VIDEO SHOWS: TIMELINE OF FIFA'S CONTROVERSIAL SHORT-LIVED PLAN TO CREATE A NEW $20-BILLION SUBSIDIARY, FIFA…
